Principal Financial Group’s Sionna Therapeutics SION Stock Holding History

Principal Financial Group’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$59.3K	Buy	+11,267	New	+$259K	﹤0.01%	2188

Other funds holding SION

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Principal Financial Group's SION Position: Q3 2026 in Review

Principal Financial Group opened a new position in Sionna Therapeutics (SION) in Q3 2026: 11,267 shares worth $59.3K. The stake represents ﹤0.01% of the portfolio and ranks #2188 among its holdings.

29 funds tracked by Wall St. Rank hold SION as of Q3 2026.

Principal Financial Group held 11,267 shares of Sionna Therapeutics worth $59.3K as of Q3 2026.
Sionna Therapeutics was a new Principal Financial Group position in Q3 2026.
Sionna Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #2188 holding.
29 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.